Prostate Cancer Cell Phenotypes Remain Stable Following PDE5 Inhibition in the Clinically Relevant Range

Widespread cGMP-specific phosphodiesterase 5 (PDE5) inhibitor use in male reproductive health and particularly in prostate cancer patients following surgery has generated interest in how these drugs affect the ability of residual tumor cells to proliferate, migrate, and form recurrent colonies. Pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Hankey, William, Sunkel, Benjamin, Yuan, Fuwen, He, Haiyan, Thomas-Ahner, Jennifer M., Chen, Zhong, Clinton, Steven K., Huang, Jiaoti, Wang, Qianben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248418/
https://www.ncbi.nlm.nih.gov/pubmed/32454444
http://dx.doi.org/10.1016/j.tranon.2020.100797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248418/
https://www.ncbi.nlm.nih.gov/pubmed/32454444
http://dx.doi.org/10.1016/j.tranon.2020.100797

Ejemplares similares